Cytokinetics, Incorporated
CYTK
Clasificación en acciones
#2266
Cytokinetics, Incorporated, a biopharmaceutical company, focuses on... Cytokinetics, Incorporated, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel muscle activators and muscle inhibitors as potential treatments for debilitating diseases in the United States. The company markets MYQORZO, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of symptomatic oHCM. It also develops Aficamten, a novel, oral, and small molecule cardiac myosin inhibitor for the treatment of HCM; and omecamtiv mecarbil, a potential treatment across the continuum of care in heart failure with severely reduced ejection fraction. In addition, the company is involved in developing and Ulacamten, a novel, selective, oral, and small molecule cardiac myosin inhibitor designed to reduce the hypercontractility associated with heart failure with preserved ejection fraction in Phase 1 clinical trials; and CK-089, a fast skeletal muscle troponin activator in Phase 1 clinical trials. Cytokinetics, Incorporated was incorporated in 1997 and is headquartered in South San Francisco, California.
Precio por acción
$64.16
Capitalización bursátil
$8.92B
Cambio (1 día)
2.40%
Cambio (1 año)
8.10%
País
US
Comercio Cytokinetics, Incorporated (CYTK)
Categoría
Healthcare
Historial de desdoblamientos de acciones de Cytokinetics, Incorporated (CYTK)
La acción Cytokinetics, Incorporated (símbolo: CYTK) tuvo un total de 1 desdoblamientos.
El desdoblamiento más reciente ocurrió el Jun 25, 2013.
Una acción CYTK comprada antes de Jun 25, 2013 equivaldría hoy a 0.16666666666667 acciones CYTK.
El desdoblamiento más reciente ocurrió el Jun 25, 2013.
Una acción CYTK comprada antes de Jun 25, 2013 equivaldría hoy a 0.16666666666667 acciones CYTK.
Lista de desdoblamientos de acciones
| Año | Desdoblamiento | Multiplicador | Multiplicador acumulado |
|---|---|---|---|
| 2013-06-25 | 1:6 | x0.16666666666667 | x0.16666666666667 |
Desdoblamientos de acciones de empresas similares o competidoras
| Empresa | Número de desdoblamientos de acciones | Multiplicador acumulado | País |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
